caretrace.iopowered by▸healthparse
SearchCohort Builder
Tools▾
KOL FinderTerritoriesDrug Compare
AI Query
Browse▾
By stateBy specialty
Pricing
SearchCohort BuilderToolsKOL FinderTerritoriesDrug CompareAI QueryBrowseBy stateBy specialtyPricing
PROVIDER PROFILE · NPI 1679681027

James OtoshiM.D.

Pulmonary DiseaseEscondido, CAI
CROSS-REFERENCE

Related data on other Healthparse brands

ProviderScore
OIG/SAM exclusion screening, sanctions history
© 2026 CareTrace
PricingContactPrivacyTerms
MEDICARE UTILIZATION · PART B · 2024
Total beneficiaries
34
Unique beneficiaries
—
Total services
595
Distinct HCPCS
2
Medicare payment
$39K
Peer benchmark
Q1
Q2
Q3
Q4
Q5
Total Medicare services vs. 901 Pulmonary Disease providers in CA — below median (cohort median 927).
REFERRAL NETWORK

Where James Otoshi's patients come from & go

Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 21 inbound referrers · 0 outbound destinations.

Receives referrals from
Inbound — who sends patients here
PhysicianPatientsVisits
PALOMAR HEALTH142524
PALOMAR HEALTH69574
NPI 124533123048138
Kiran Patel
Diagnostic Radiology · Oceanside, CA
48155
Jeffrey Miller
Diagnostic Radiology · Oceanside, CA
4494
Tan Nguyen
Diagnostic Radiology · Dallas, TX
3575
NPI 106347342931105
William Kakimoto
Diagnostic Radiology · La Jolla, CA
2968
Craig Burrows
Pulmonary Disease · Escondido, CA
29110
Michael Noud
Diagnostic Radiology · Oceanside, CA
28102
Kenneth Trestman
Pulmonary Disease · Encinitas, CA
2760
Sean Pinnell
Diagnostic Radiology · Vista, CA
2456
Refers patients to
Outbound — where patients go next
No outbound pairs above the suppression threshold.
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
QUALITY · MIPS · 2024
No data available for this provider in 2024.
PRESCRIBING · PART D · 2024
Total Rx claims
1,206
Beneficiaries
—
Total drug cost
$106K
Distinct drugs
38
Brand share
31.1%
Top prescribed drugs
0.9 % Sodium Chloride135 claims
Potassium Chloride76 claims
Ipratropium/Albuterol Sulfate75 claims
Baclofen60 claims
Famotidine58 claims
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2024
Total received
$178
Payment records
3
By payment type
Food and Beverage$178